Fig 1: Serum PCSK9 and serum syndecan-1 levels in saline-treated, heparin-treated, RO-heparin-treated, and NAc-heparin-treated groups. (A) Serum PCSK9 levels, (B) serum PCSK9 expressed as fold changes, and (C) serum syndecan-1 levels. Data are shown as mean ± SEM.
Fig 2: Concentrations of PCSK9 (ng/mL) in blood plasma (A) and liver tissue (B). Bar heights correspond to averages and error bars represent standard deviations. Statistical significance markers: a—vs. Control (p < 0.05), b—vs. HFD (p < 0.05).
Fig 3: Effect of free running wheel activity (R) on plasma PCSK9, LDL, HDL, and glucose concentrations and comparison between both strains. Data are box plots representing the 25, 50, and 75% quartile and the whiskers representing the total range.
Supplier Page from CUSABIO Technology LLC for Rat Proprotein convertase subtilisin/kexin type 9(PCSK9) ELISA Kit